Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study

Prediction of Creatinine Clearance from Serum Creatinine

Donald W. Cockcroft, Henry Gault · ˜The œNephron journals/Nephron journals · 2008 · 15.4K citations

Pharmacy, Nephrology, Pharmacokinetics +15

Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

Michael Gnant, Brigitte Mlineritsch, Walter Schippinger et al. · New England Journal of Medicine · 2009 · 1K citations · Full text

Medicine, Oncology, Pharmacology +13

Ovarian Failure After Adjuvant Chemotherapy Is Associated With Rapid Bone Loss in Women With Early-Stage Breast Cancer

Charles L. Shapiro, Judith Manola, Meryl S. LeBoff · Journal of Clinical Oncology · 2001 · 437 citations

Medicine, Gynecology, Oncology +17

Breast-Cancer Adjuvant Therapy with Zoledronic Acid

New England Journal of Medicine · 2011 · 420 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

Michael Gnant, Brigitte Mlineritsch, G. Luschin-Ebengreuth et al. · The Lancet Oncology · 2008 · 397 citations

Medicine, Oncology, Pharmacotherapy +17